Somatostatin analog therapy effectiveness on the progression of polycystic kidney and liver disease: A systematic review and meta-analysis of randomized clinical trials

BACKGROUND: Uncertainty underlies the effectiveness of somatostatin analogues for slowing the progression of polycystic kidney or liver disease. METHODS: Eligible studies included randomized controlled trials (RCTs) evaluating somatostatin analog as therapy for patients with polycystic kidney diseas...

Descripción completa

Detalles Bibliográficos
Autores principales: Suwabe, Tatsuya, Barrera, Francisco J., Rodriguez-Gutierrez, Rene, Ubara, Yoshifumi, Hogan, Marie C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462725/
https://www.ncbi.nlm.nih.gov/pubmed/34559824
http://dx.doi.org/10.1371/journal.pone.0257606

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462725/
https://www.ncbi.nlm.nih.gov/pubmed/34559824
http://dx.doi.org/10.1371/journal.pone.0257606

Ejemplares similares